Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Advocating for rituximab as first-line treatment for NMOSD-AQP4 patients in France: Cost and efficacy considerations.
Deschamps R, Papeix C, Ayrignac X, Bourre B, Ciron J, Cohen M, Collongues N, Deiva K, Durand Dubief F, Laplaud DA, Maillart E, Michel L, Pique J, Ruet A, Thouvenot E, Zéphir H, Marignier R, Audoin B. Deschamps R, et al. Among authors: laplaud da. Rev Neurol (Paris). 2024 Oct;180(8):711-714. doi: 10.1016/j.neurol.2024.06.003. Epub 2024 Jul 4. Rev Neurol (Paris). 2024. PMID: 38969609 No abstract available.
Emotional facial palsy following striato-capsular infarction.
Michel L, Derkinderen P, Laplaud D, Daumas-Duport B, Auffray-Calvier E, Lebouvier T. Michel L, et al. J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):193-4. doi: 10.1136/jnnp.2007.131813. J Neurol Neurosurg Psychiatry. 2008. PMID: 18202207
Neuromyelitis optica in France: a multicenter study of 125 patients.
Collongues N, Marignier R, Zéphir H, Papeix C, Blanc F, Ritleng C, Tchikviladzé M, Outteryck O, Vukusic S, Fleury M, Fontaine B, Brassat D, Clanet M, Milh M, Pelletier J, Audoin B, Ruet A, Lebrun-Frenay C, Thouvenot E, Camu W, Debouverie M, Créange A, Moreau T, Labauge P, Castelnovo G, Edan G, Le Page E, Defer G, Barroso B, Heinzlef O, Gout O, Rodriguez D, Wiertlewski S, Laplaud D, Borgel F, Tourniaire P, Grimaud J, Brochet B, Vermersch P, Confavreux C, de Seze J. Collongues N, et al. Neurology. 2010 Mar 2;74(9):736-42. doi: 10.1212/WNL.0b013e3181d31e35. Neurology. 2010. PMID: 20194912
[Natural history of adult-onset eIF2B-related disorders: a multicentric survey of 24 cases].
Carra-Dalliere C, Horzinski L, Ayrignac X, Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, Confavreux C, Obadia M, Blanc F, de Seze J, Sedel F, Guennoc AM, Sartori E, Laplaud D, Antoine JC, Fogli A, Boespflug-Tanguy O, Labauge P. Carra-Dalliere C, et al. Rev Neurol (Paris). 2011 Nov;167(11):802-11. doi: 10.1016/j.neurol.2011.03.008. Epub 2011 Jun 14. Rev Neurol (Paris). 2011. PMID: 21676421 French.
Recommendations for useful serum testing with suspected multiple sclerosis.
Ouallet JC, Bodiguel E, Bensa C, Blanc F, Brassat D, Laplaud D, Zephir H, de Seze J, Magy L; Groupe de Re´flexion sur la Scle´rose en Plaques: GRESE. Ouallet JC, et al. Rev Neurol (Paris). 2013 Jan;169(1):37-46. doi: 10.1016/j.neurol.2011.09.007. Epub 2012 Feb 8. Rev Neurol (Paris). 2013. PMID: 22325711
Recommendations for a definition of multiple sclerosis in support of early treatment.
Zéphir H, Bodiguel E, Bensa C, Blanc F, Laplaud D, Magy L, Ouallet JC, De Seze J, Brassat D; GRESEP (Groupe de Reflexion sur la Sclerose en Plaques; Multiple Sclerosis Think Tank). Zéphir H, et al. Rev Neurol (Paris). 2012 Apr;168(4):328-37. doi: 10.1016/j.neurol.2011.12.008. Epub 2012 Mar 6. Rev Neurol (Paris). 2012. PMID: 22398217
Recommendations for the management of multiple sclerosis relapses.
Laplaud D, Bodiguel E, Bensa C, Blanc F, Brassat D, Magy L, Ouallet JC, Zephir H, De Seze J; GRESEP (Groupe de Reflexion sur la Sclerose en Plaques; Multiple Sclerosis Think Tank). Laplaud D, et al. Rev Neurol (Paris). 2012 May;168(5):425-33. doi: 10.1016/j.neurol.2012.02.006. Epub 2012 May 1. Rev Neurol (Paris). 2012. PMID: 22555010
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
Outteryck O, Ongagna JC, Brochet B, Rumbach L, Lebrun-Frenay C, Debouverie M, Zéphir H, Ouallet JC, Berger E, Cohen M, Pittion S, Laplaud D, Wiertlewski S, Cabre P, Pelletier J, Rico A, Defer G, Derache N, Camu W, Thouvenot E, Moreau T, Fromont A, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Casez O, Hautecoeur P, Papeix C, Lubetzki C, Fontaine B, Couturier N, Bohossian N, Clanet M, Vermersch P, de Sèze J, Brassat D; BIONAT Network,; CFSEP. Outteryck O, et al. Eur J Neurol. 2014;21(1):40-8. doi: 10.1111/ene.12204. Epub 2013 Jun 12. Eur J Neurol. 2014. PMID: 23895407 Clinical Trial.
132 results